AMG-609 5'-MODIFICATION SODIUM (TRIS-N-ACETYLGALACTOSAMINE GLYCOPEPTIDE-AMINOHEXYL-5'-THIOPHOSPHO-2'-O-METHYLCYTIDINE)
UNII BZ637PY7BV
Substance Identification & Data
This profile provides standardized clinical and technical data for Amg-609 5'-modification Sodium (tris-n-acetylgalactosamine Glycopeptide-aminohexyl-5'-thiophospho-2'-o-methylcytidine), uniquely identified by the FDA Unique Ingredient Identifier (UNII) BZ637PY7BV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C73H126N12O31PS.Na AVCSHIPVMFPKTH-MTLJDUNASA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Amg-609 5'-modification Sodium (tris-n-acetylgalactosamine Glycopeptide-aminohexyl-5'-thiophospho-2'-o-methylcytidine). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.